Dalgety supplies pharma-grade cannabis directly to the medical industry for use in prescription medications.
We produce a wide range of finished cannabis products, from dried flower to concentrated extracts including crystals, liquids and concentrates. All our products are grown in-house and harvested within our state-of-the-art facility to ensure quality.
The controlled growing process we use ensures that our products can be consistently high in THC, CBD, CBA, CBN and a range of other cannabinoids. Our expert growers and research team can develop genetic hybrids that will deliver API profiles to specific customer requirements.
Dalgety can supply finished products as:
Dalgety supply’s products directly to the medical industry, from manufacturers of licenced, unlicenced and special medicines or direct to pharmacies, doctors and licenced medical clinics. As such we can provide our products in bulk or packaged into final end use containers.
By supplying direct to pharmaceutical manufacturers and the medical sector we can underpin confidence in quality and potency.
Medical cannabis is used in the treatment of chronic pain, Parkinson’s disease, MS, epilepsy, or to relieve symptoms of the side effects of chemotherapy. Research is ongoing to review its effectiveness in the treatment of Alzheimer’s, Crohn’s disease, PTSD, sleep issues, anxiety, rheumatoid arthritis, heart conditions and many other medical issues. Medical cannabis is being studied as an alternative to opiates and synthetic products as a treatment.
Dalgety is proud to be at the forefront of medical grown cannabis in the UK.